Abstract
Anticancer drug delivery has been hindered due to cell membrane permeability and the lack of a selective marker for tumor cells. Cell permeability is related to the bioavailability of drugs and has therefore been considered to be an essential step for achieving therapeutic efficacy. While different types of transporters currently exist, cell penetrating peptides (CPPs) have become one of the most popular and effective tools for intracellular drug delivery. Most of the original CPPs are short peptides with basic residues. The mechanism of CPP cell entry remains to be established; however, the CPPs can deliver any type of molecular cargo including solid nanoparticles. Herein, this paper will discuss the classification of CPPs, the mechanism of cell entry, the application of CPPs in tumor therapy, and recent advances in targeted cell penetration that involve CPPs.
Keywords: Antitumor drug delivery, cell penetrating peptides (cpp), molecular cargo, intracellular drug delivery, bioavailability of drugs, therapeutic efficacy, cell penetrating peptides (CPPs), solid nanoparticles, cargo translocation, cell-penetrating peptides
Current Pharmaceutical Biotechnology
Title: Cell Penetrating Peptides for Tumor Targeting
Volume: 12 Issue: 8
Author(s): Young Suk Choi, Jue Yeon Lee, Jin Sook Suh, Seung Jin Lee, Victor C. Yang, Chong Pyoung Chung and Yoon Jeong Park
Affiliation:
Keywords: Antitumor drug delivery, cell penetrating peptides (cpp), molecular cargo, intracellular drug delivery, bioavailability of drugs, therapeutic efficacy, cell penetrating peptides (CPPs), solid nanoparticles, cargo translocation, cell-penetrating peptides
Abstract: Anticancer drug delivery has been hindered due to cell membrane permeability and the lack of a selective marker for tumor cells. Cell permeability is related to the bioavailability of drugs and has therefore been considered to be an essential step for achieving therapeutic efficacy. While different types of transporters currently exist, cell penetrating peptides (CPPs) have become one of the most popular and effective tools for intracellular drug delivery. Most of the original CPPs are short peptides with basic residues. The mechanism of CPP cell entry remains to be established; however, the CPPs can deliver any type of molecular cargo including solid nanoparticles. Herein, this paper will discuss the classification of CPPs, the mechanism of cell entry, the application of CPPs in tumor therapy, and recent advances in targeted cell penetration that involve CPPs.
Export Options
About this article
Cite this article as:
Suk Choi Young, Yeon Lee Jue, Sook Suh Jin, Jin Lee Seung, C. Yang Victor, Pyoung Chung Chong and Jeong Park Yoon, Cell Penetrating Peptides for Tumor Targeting, Current Pharmaceutical Biotechnology 2011; 12 (8) . https://dx.doi.org/10.2174/138920111796117391
DOI https://dx.doi.org/10.2174/138920111796117391 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Analysis of the In Vivo Metabolism and Biodistribution of Metabolically and Non-Metabolically Activated Combi-Molecules of the Triazene Class
Drug Metabolism Letters Transition Metal-mediated Uncaging Chemistry in Prodrug Design
Current Topics in Medicinal Chemistry Realizing the Potential of Blueberry as Natural Inhibitor of Metastasis and Powerful Apoptosis Inducer: Tapping the Treasure Trove for Effective Regulation of Cell Signaling Pathways
Anti-Cancer Agents in Medicinal Chemistry C-11 Radiochemistry in Cancer Imaging Applications
Current Topics in Medicinal Chemistry Current Research on Opioid Receptor Function
Current Drug Targets Editorial from Guest Editor (DNA Methylation: A Target for Current and Future Therapies?)
Epigenetic Diagnosis & Therapy (Discontinued) Surface Plasmon Resonance Imaging Sensor for Cathepsin Determination Based on Immobilized Cystatin
Protein & Peptide Letters Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism Targeting the Tumor Proteasome as a Mechanism to Control the Synthesis and Bioactivity of Matrix Macromolecules
Current Molecular Medicine PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development
Current Drug Targets Radioactive Nanoparticles and their Main Applications: Recent Advances
Recent Patents on Nanotechnology Meet Our Editorial Board Member
Current Cancer Therapy Reviews Lipid Metabolism and Mitochondria: Cross Talk in Cancer
Current Drug Targets Improvement of Adoptive Cellular Immunotherapy of Human Cancer Using Ex-Vivo Gene Transfer
Current Gene Therapy Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry Positron Emitting Tracers in Pre-Clinical Drug Development
Current Radiopharmaceuticals The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
Current Cancer Drug Targets Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design A Decrease in the Cellular Phosphodiester to Phosphomonoester Lipid Ratio is Characteristic of HIV-1 Infection
Current HIV Research Expression of P-gp in Glioblastoma: What we can Learn from Brain Development
Current Pharmaceutical Design